Clinical Trials in Rheumatoid Arthritis and Osteoarthritis

1. Introduction
David M. Reid, Colin G. Miller

2. Historical and Current Perspectives on Management of Osteoarthritis and Rheumatoid Arthritis
Shirish Dubey, Adewale O. Adebajo

3. Development of Biological Therapies for Inflammatory Arthritis
Neil Basu

4. Study Design and End Points for Rheumatoid Arthritis Trials
Pieter Geusens, Colin G. Miller

5. Study Design and End Points in Ankylosing Spondylitis Clinical Trials
Dèsirèe Heijde

6. Trial Design and Outcomes in Osteoarthritis
Nigel Arden

7. Ethical Considerations
Derek Pearson, Colin G. Miller

8. Organization of the Clinical Trial by the Sponsor
Colin G. Miller

9. Organization of the Trial attheInvestigator Site
Julie Shotton, David M. Reid, Colin G. Miller

10. Role of the Imaging Core Laboratory in Rheumatoid Arthritis and Osteoarthritis Clinical Trials
Mark D. Endres, Anna M. Baratelle

11. Biochemical Markers of Rheumatoid Arthritis and Osteoarthritis: Clinical Utility and Practical Considerations
Mario R. Ehlers, Elizabeth T. Leary

12. Data Analysis and Presentation: Writing a Paper for Publication
Derek Pearson

13. Radiographic Imaging End Points in Rheumatoid Arthritis Trials
Anna M. Baratelle, Désirée van der Heijde

14. Radiography in Clinical Trials Investigating Osteoarthritis
Cornelis Kuijk

15. Use of Quantitative Magnetic Resonance Imaging in the Cross-Sectional and Longitudinal Evaluation of Structural Changes in Knee Osteoarthritis Patients
Jean-Pierre Raynauld, Johanne Martel-Pelletier, François Abram, Jean-Pierre Pelletier

16. Biochemical Markers as Surrogate End Points of Joint Disease
L. Stefan Lohmander, David R. Eyre

17. Role of Genetics and Genomics in Clinical Trials in Osteoarthritis and Rheumatoid Arthritis
Stuart H. Ralston

18. Cost-Effectiveness of New Biologics for Rheumatoid Arthritis and Osteoarthritis
Yolanda Bravo Vergel, David Torgerson

DRM-restrictions

Printing: not available
Clipboard copying: not available

Keywords: MEDICAL / Public Health MED078000